Immune-related gene risk score predicting the effect of immunotherapy and prognosis in bladder cancer patients.

Zou, Yuantao; Yuan, Gangjun; Tan, Xingliang; Luo, Sihao; Yang, Cong; Tang, Yi; Wang, Yanjun; Yao, Kai

Zou, Yuantao; Yuan, Gangjun; Tan, Xingliang; Luo, Sihao; Yang, Cong; Tang, Yi; Wang, Yanjun; Yao, Kai.

Afiliação

Zou Y; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Yuan G; State Key Laboratory of Oncology in Southern China, Guangzhou, China.
Tan X; Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
Luo S; Department of Urology Oncological Surgery, Chongqing University Cancer Hospital, Chongqing, China.
Yang C; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Tang Y; State Key Laboratory of Oncology in Southern China, Guangzhou, China.
Wang Y; Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
Yao K; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China.

Front Genet ; 13: 1011390, 2022.

Article em En | MEDLINE | ID: mdl-36267410

Palavras-chave

IRGRS; bladder cancer; immunotherapy; microenvironemnt; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google